(Q51909974)

17 April 2018

title

Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure. (English)

1 reference

17 April 2018

0 references

4

1 reference

17 April 2018

author name string

Ogo I Egbuna

series ordinal

1

1 reference

17 April 2018

Jeremy G Taylor

series ordinal

2

1 reference

17 April 2018

David A Bushinsky

series ordinal

3

1 reference

17 April 2018

publication date

1 July 2007

1 reference

17 April 2018

published in

Clinical Transplantation

1 reference

17 April 2018

volume

21

1 reference

17 April 2018

page(s)

558-566

1 reference

17 April 2018

issue

4

1 reference

17 April 2018

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Current status of kidney and pancreas transplantation in the United States, 1994-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Natural history of vascular calcification in dialysis and transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Assessment of vascular calcification in ESRD patients using spiral CT

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Long-term follow-up study on bone mineral density and fractures after simultaneous pancreas-kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Bone loss in the early period after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Percutaneous penetration of topically applied melatonin in a cream and an alcoholic solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Bone disease after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Calcium and calcitriol prophylaxis attenuates posttransplant bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Pamidronate used to attenuate post-renal transplant bone loss is not associated with renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Incidence of hip osteonecrosis among renal transplantation recipients: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Long-term fracture risk following renal transplantation: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Reduced parathyroid functional mass after successful kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Polycystin-1 activates the calcineurin/NFAT (nuclear factor of activated T-cells) signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Do polycystins function as cation channels?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Intratubular calcification in a post-renal transplanted patient with secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00690.X

10.1111/J.1399-0012.2007.00690.X

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

PubMed ID

17645720

1 reference

17 April 2018